Qt Imaging Holdings, Inc. (QTIWW)
QTIWW is quoted over the counter, not listed on an exchange. Qt Imaging Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Profile
| Field | Value |
|---|---|
| Ticker | QTIWW, quoted over the counter |
| SEC CIK | 0001844505 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Business address | Petaluma, CA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $8.1M cash; operating cash flow -$3.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 14,692,216 (2026-11-09); 11,902,198 a year earlier; 8,659,978 three years earlier. 3y figure adjusted for splits (1-for-15 overall). | Cover page 2026-11-09 |
| Reverse splits, 3 years | 2; latest 1-for-5 on 2025-10-27 | Source 2025-10-27 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-05-15 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-07-21 |
| Auditor | BPM LLP, San Jose, California, United States | PCAOB Form AP 2026-03-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $155K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $7.3M | -$297K | -$2.2M | $8.1M | $11.4M | $29.6M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $7.4M | -$11.1M | -$4.8M | $10.9M | $11.4M | $26.4M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $6.5M | -$3.4M | -$3.7M | $6.9M | $10.1M | $22.7M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $8.3M | -$1.4M | -$3.1M | $10.4M | $10.1M | $18.9M | 10-K 2026-03-25 |
| Q3 2025 2025-09-30 | $4.2M | -$4.6M | -$879K | $1.7M | $15.1M | $11.5M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $3.7M | -$4.0M | -$1.4M | $2.0M | $10.1M | $8.3M | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $2.8M | -$11.1M | -$3.5M | $3.0M | $10.2M | $6.3M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $847K | -$3.5M | -$1.2M | $1.2M | $9.9M | $4.9M | 10-K 2026-03-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-15 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEF 14A | 2026-07-02 |
Source: SEC EDGAR submissions feed, 433 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier